{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:59:42Z","timestamp":1790143182391,"version":"4.0.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Accumulated evidence has implicated that brain-derived neurotrophic factor (BDNF) gene polymorphisms play a role in the etiology of obsessive-compulsive disorder (OCD). A single nucleotide polymorphism in the coding exon of the BDNF gene at position 66, Val66Met (rs6265), is found to be associated with OCD in different populations, but results linking Val66Met with OCD have been inconsistent and inconclusive. In our study we performed a meta-analysis to further examine whether rs6265 genetic variants are involved in the etiology of OCD.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> By searching databases, relevant case-control studies were retrieved; using established inclusion criteria, we selected eligible studies for analysis.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Thirteen studies were identified that examined the association between the rs6265 polymorphism and OCD. After statistical analyses, no significant association was found between the rs6265 polymorphism and OCD (OR = 1.07, 95% CI = 1.00\u20131.15, <jats:italic>P<\/jats:italic> = 0.06 for genotype; OR = 1.06, 95% CI = 0.98\u20131.15, <jats:italic>P<\/jats:italic> = 0.15 for allele). However, in gender-specific analysis, female Val carriers might be a risk factor for OCD (OR = 1.36, 95% CI = 1.03\u20131.80, <jats:italic>P<\/jats:italic> = 0.03 for genotype; OR = 1.15, 95% CI = 1.01\u20131.32, <jats:italic>P<\/jats:italic> = 0.04 for allele).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our updated meta-analysis suggests that female carriers of the Val66Met BDNF polymorphism might be more suspectable to develop OCD.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.685041","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T06:49:42Z","timestamp":1641970182000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Is Associated With Female Obsessive-Compulsive Disorder: An Updated Meta-Analysis of 2765 Obsessive-Compulsive Disorder Cases and 5558 Controls"],"prefix":"10.3389","volume":"12","author":[{"given":"Yanan","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengfen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1375\/twin.8.5.450","article-title":"Twin studies on obsessive-compulsive disorder: a review","volume":"8","author":"van Grootheest","year":"2005","journal-title":"Twin Res Hum Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrn3379","article-title":"Neurotrophin regulation of neural circuit development and function","volume":"14","author":"Park","year":"2013","journal-title":"Nat Rev Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"11","author":"Bathina","year":"2015","journal-title":"Arch Med Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s10571-020-00788-4","article-title":"Effect of escitalopram on serum GDNF and BDNF levels and 5-HT level of brain tissue of obsessive-compulsive disorder rats","volume":"40","author":"Guo","year":"2020","journal-title":"Cell Mol Neurobiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jad.2009.07.009","article-title":"Serum levels of brain-derived neurotrophic factor in drug-na?ve obsessive-compulsive patients: a case -control study","volume":"122","author":"Maina","year":"2010","journal-title":"J Affect Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jad.2011.04.002","article-title":"Brain-derived neurotrophic factor (BDNF) plasma levels in drug-na?ve OCD patients are lower than those in healthy people, but are not lower than those in drug-treated OCD patients","volume":"133","author":"Wang","year":"2011","journal-title":"J Affect Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1126\/science.1129663","article-title":"Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior","volume":"314","author":"Chen","year":"2006","journal-title":"Science."},{"key":"B8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.24869\/psyd.2019.141","article-title":"Is Brain-Derived Neurotrophic Factor (BDNF) Val66Met polymorphism associated with obsessive-compulsive disorder? A meta-analysis","volume":"31","author":"Wang","year":"2019","journal-title":"Psychiatria Danubina."},{"key":"B9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jad.2013.03.016","article-title":"Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: a meta-analysis","volume":"150","author":"Zhao","year":"2013","journal-title":"J Affect Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1038\/sj.npp.1301394","article-title":"A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder","volume":"32","author":"Wendland","year":"2007","journal-title":"Neuropsychopharmacology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/15622970701245003","article-title":"Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive- compulsive disorder (OCD)","volume":"9","author":"Hemmings","year":"2008","journal-title":"World J Biol Psychiatry."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/ajmg.b.30930","article-title":"The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD)","author":"Katerberg","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3969\/j.issn.1002-0152.2009.10.013","article-title":"Association study of brain-derived neurotrophic factor gene polymorphism with generalized anxiety disorder and obsessive-compulsive disorder","volume":"10","author":"Wang","year":"2009","journal-title":"Chin J Neuropsychiatr Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1590\/S1516-44462010000300023","article-title":"Positive association between MET allele (BDNF Val66Met polymorphism) and obsessive-compulsive disorder","volume":"32","author":"Da Rocha","year":"2010","journal-title":"Rev Bras Psiquiatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/ajmg.b.32092","article-title":"Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder","author":"T\u00fckel","year":"2012","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.euroneuro.2013.08.001","article-title":"Association study between BDNF gene variants and Mexican patients with obsessive-compulsive disorder","volume":"23","author":"M\u00e1rquez","year":"2013","journal-title":"Eur Neuropsychopharmacol."},{"key":"B17","first-page":"29","article-title":"Association study of brain-derived neurotrophic factor (BDNF) genetic polymorphism and obsessivecompulsive disorder","volume":"1","author":"Liu","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jpsychires.2013.08.012","article-title":"BDNF Val66Met modifies the risk of childhood trauma on obsessive-compulsive disorder","volume":"47","author":"Hemmings","year":"2013","journal-title":"J Psychiatr Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3109\/15622975.2015.1012226","article-title":"Do obsessive-compulsive disorder and Tourette syndrome share a common susceptibility gene? An association study of the BDNF Val66Met polymorphism in the Chinese Han population","volume":"16","author":"Liu","year":"2015","journal-title":"World J Biol Psychiatry."},{"key":"B20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1017\/neu.2015.38","article-title":"Meta-analysis of the association of brain-derived neurotrophic factor Val66Met polymorphism with obsessive-compulsive disorder","volume":"27","author":"Wang","year":"2015","journal-title":"Acta Neuropsychiatr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2147\/NDT.S102100","article-title":"No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population","volume":"12","author":"Umehara","year":"2016","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajp.2017.10.014","article-title":"BDNF gene and obsessive compulsive disorder risk, symptom dimensions and treatment response","volume":"38","author":"Taj MJ","year":"2018","journal-title":"Asian J Psychiatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/00048679509075899","article-title":"Gender differences in obsessive compulsive disorder","volume":"29","author":"Castle","year":"1995","journal-title":"Aust N Z J Psychiatry."},{"key":"B24","first-page":"236","article-title":"Associations between brain-derived neurotrophic factor and estradiol in women's saliva","volume":"35","author":"Matsuki","year":"2014","journal-title":"Neuro Endocrinol Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"11110","DOI":"10.1073\/pnas.92.24.11110","article-title":"Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor","volume":"92","author":"Sohrabji","year":"1995","journal-title":"Proc Natl Acad Sci USA."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1523\/JNEUROSCI.19-04-01179.1999","article-title":"Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways","volume":"19","author":"Singh","year":"1999","journal-title":"J Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.pnpbp.2008.04.002","article-title":"Hippocampus and amygdalar volumes in patients with refractory obsessive-compulsive disorder","volume":"32","author":"Atmaca","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1192\/bjp.bp.115.164020","article-title":"Cortical thickness in obsessive-compulsive disorder: multisite mega-analysis of 780 brain scans from six centres","volume":"210","author":"Fouche","year":"2017","journal-title":"Br J Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1176\/appi.ajp.160.7.1242","article-title":"Schizophrenia, III: brain-derived neurotropic factor and genetic risk","volume":"160","author":"Egan","year":"2003","journal-title":"Am J Psychiatry."},{"key":"B30","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1523\/JNEUROSCI.23-17-06690.2003","article-title":"Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance","volume":"23","author":"Hariri","year":"2003","journal-title":"J Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/mp.2009.24","article-title":"Population genetic study of the brain-derived neurotrophic factor (BDNF) gene","volume":"15","author":"Petryshen","year":"2010","journal-title":"Mol Psychiatry."},{"key":"B33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1086\/377003","article-title":"Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder","volume":"73","author":"Hall","year":"2003","journal-title":"Am J Hum Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00041444-200512000-00002","article-title":"No association between brain-derived neurotrophic factor gene and obsessive-compulsive disorder","volume":"15","author":"Zai","year":"2005","journal-title":"Psychiatr Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.biopsych.2007.06.020","article-title":"Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder","volume":"63","author":"Alonso","year":"2008","journal-title":"Biol Psychiatry."},{"key":"B36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.schres.2013.01.020","article-title":"Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia","volume":"146","author":"Zhang","year":"2013","journal-title":"Schizophr Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science."},{"key":"B38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.psychres.2010.04.001","article-title":"Interaction effects between COMT and BDNF polymorphisms on boredom susceptibility of sensation seeking traits","volume":"178","author":"Kang","year":"2010","journal-title":"Psychiatry Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.comppsych.2004.02.010","article-title":"Life events and personality factors in children and adolescents with obsessive-compulsive disorder and other anxiety disorders","volume":"45","author":"Gothelf","year":"2004","journal-title":"Comprehen psychiatry."},{"key":"B40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/NMD.0000000000001260","article-title":"Obsessive-compulsive disorder in women: any gender-based differences?","volume":"209","author":"Naguy","year":"2021","journal-title":"J Nerv Ment Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1192\/bjp.177.5.457","article-title":"Personality disorders and normal personality dimensions in obsessive-compulsive disorder","volume":"177","author":"Samuels","year":"2000","journal-title":"Brit J Psychiatry."},{"key":"B42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.eurpsy.2014.11.008","article-title":"Are stressful life events causally related to the severity of obsessive-compulsive symptoms? A monozygotic twin difference study","volume":"30","author":"Vidal-Ribas","year":"2015","journal-title":"Eur Psychiatry."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.685041\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T06:49:51Z","timestamp":1641970191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.685041\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":42,"alternative-id":["10.3389\/fpsyt.2021.685041"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.685041","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,12]]},"article-number":"685041"}}